Author: user

New Approach for Carbon Buyers to Secure High-Quality Credits and Support Family ForestsWASHINGTON, Oct. 15, 2024 /PRNewswire/ — The American Forest Foundation (AFF) will hold the first auction for the Family Forest Carbon Program’s carbon credits in February 2025. The American Forest Foundation Carbon Auction — the first of its kind for a U.S. nature-based carbon project — will offer buyers a transparent and streamlined way to secure high-quality carbon credits while supporting rural communities and family forest owners. Tim Stout, a Family Forest Carbon Program enrolled landowner from Vermont, stands in the woods he stewards. More companies than ever…

Read More

MIAMI, FL – Gaucho Group Holdings, Inc. (NASDAQ:VINO), known for its luxury real estate and fine wine offerings, announced today that its subsidiary, Algodon Fine Wines, has launched a collection of premium Argentine wines in the United States. This latest release features a range of Malbecs and exclusive blends from the vineyards of Algodon Wine Estates in Argentina’s San Rafael region. The collection includes the Algodon Estate Malbec 2022, Algodon Estate Bonarda 2022, Algodon Estate Chardonnay 2023, and a selection of microvinified black label wines such as Cabernet Fran-Malbec Reserve 2020, Gran Cuvee 2021, and PIMA 2021. Additionally, the collection…

Read More

Catherine Keating is the Global Head of BNY Wealth, the wealth management arm of BNY Mellon. In an interview for “Bloomberg Wealth with David Rubenstein,” Keating talks about why elections are about policy and advises their clients to “not invest with your politics.” Keating says that markets tend to do well, regardless of the party that’s in the White House. This interview was recorded October 3 in New York. (Source: Bloomberg) Source link

Read More

UnitedHealth Q3 Earnings: Revenue And EPS Beat, Revises Annual Profit Guidance As Change Healthcare Cyberattack Still BitesOn Tuesday, UnitedHealth Group (NYSE:UNH) reported better-than-expected third-quarter 2024 earnings but lowered the upper end of its annual EPS outlook.The company reported adjusted EPS of $7.15, up from $6.56 a year ago, beating the consensus of $7.00.UnitedHealth’s revenues increased nearly $8.5 billion (+9.1% Y/Y) to $100.8 billion, beating the consensus of $99.28 billion. This was led by an expansion in the number of people served domestically at Optum and UnitedHealthcare.Third-quarter earnings from operations were $8.7 billion, including $0.3 billion in unfavorable cyber attack effects. Adjusted earnings from operations…

Read More

Image source: Getty Images Nvidia (NASDAQ: NVDA) stock is rallying hard again, and at $138, sits just off a record high. This gives the heavyweight AI chipmaker a market cap of $3.39trn. For context, that’s more than the GDP of the UK! The tech share has now surged 178% in 2024, making it the second-best performer in the S&P 500. Yes, that’s right, there’s one stock that’s done even better! That’s Vistra, an energy company whose share price has rocketed 243% year to date due to a surge in AI-fuelled power demand. But that’s not the one I’d buy. A…

Read More

(Reuters) – Boeing (NYSE:) filed papers with the U.S. markets regulator on Tuesday for raising up to $25 billion through a stock and debt offering and entered into a $10 billion credit agreement amid a crippling strike and upcoming debt maturities. The planemaker is looking to strengthen its finances that have been strained due to a slump in production of its best-selling 737 MAX jet following a door panel blowout and a strike by thousands of union workers. It was not clear when and how much Boeing will raise via the stock offering, but analysts and investors expect the company…

Read More

The shares have experienced a pullback in the past couple of weeks. No stock has unlimited upside potential. When a company’s shares rise significantly during a short period, it makes sense to wonder whether it’s still worth investing in, even if it boasts solid fundamentals: Overvalued stocks are much less likely to generate strong returns. That brings us to Summit Therapeutics (SMMT 1.50%), a drugmaker whose shares have skyrocketed by almost 700% since the year started (although that’s down from a gain of as much as a 1,100%). The biotech is clearly doing something right, but have latecomers already missed…

Read More

Tuesday, Baird reiterated its Outperform rating on Global Payments Inc. (NYSE:) with a steady price target of $150.00. The firm’s analysis anticipates that the company’s third-quarter earnings per share (EPS) will align with expectations, noting that the Merchant segment might experience a slight slowdown. However, the impact of foreign exchange rates could offer some benefits, differing slightly from initial expectations. The analyst from Baird expressed a belief in the positive risk/reward balance for Global Payments, citing the stock’s valuation at approximately 7.5 times the estimated EPS for 2025. This valuation comes with expectations of a 10-15% growth in EPS. While…

Read More